Last update: 31 August 2016
Note: This webinar took place on Monday 28 September 2015. You can find a video recording and the presentation used during the webinar below.
Webinar introduction
HTA is a multidisciplinary process that examines the information about medical, cost-effectiveness, social, political, legal and ethical considerations of the application of a health technology – usually a medicine, medical device or clinical/surgical procedure. The main purpose of conducting an assessment is to inform policy decision making, which has an impact on patients and their ecosystem of health, including physicians and payers.
The webinar will examine the need for patient involvement in HTA and look at the HTA landscape in Europe. A patient organisation representative will present a case study on patient participation in HTA, and the conversation will also look at how the EUPATI toolkit can help informed patients engage in HTA.
Webinar agenda
| Time | Agenda |
|---|---|
| 17.00 | Welcome and introductions Daphnee Pushparajah, UCB |
| 17.10 | “HTA Introduction?” Karen Facey, Coordinator – HTAi Patient Involvement Methods and Impact Working Grouper |
| 17.25 | “Good practices in patient involvement in HTA. Are they being used?” Karen Facey, Coordinator – HTAi Patient Involvement Methods and Impact Working Grouper |
| 17.40 | “Patients’ voice in access decisions. A discussion of the roles patients can play.” Nick Meade, Director of Policy, Genetic Alliance UK |
| 18.05 | Q & A – Panel members: All presenters |
| 18.30 | Close of the Webinar |
Webinar recording
Download HTA Infographic
Webinar presentations
Presentation 1: Good practices in patient involvement in HTA. Are they being used?
Speaker: Karen Facey, Coordinator – HTAi Patient Involvement Methods and Impact Working Group
Presentation 2: Patients’ voice in access decisions. A discussion of the roles patients can play.
Speaker: Nick Meade, Director of Policy, Genetic Alliance UK
Presentation 3: Health Technology Assessment.